{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:04:56Z","timestamp":1792001096709,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 111-2314-B-182A-046"],"award-info":[{"award-number":["MOST 111-2314-B-182A-046"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Osteoradionecrosis (ORN) of the jaw requires a differential diagnosis to exclude cancer recurrence. Here, we sought to develop a scoring system comprising\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT parameters for distinguishing between the two conditions in patients with oral squamous cell carcinoma (OSCC).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The study consisted of 103 OSCC patients with suspected ORN of the jaw. All participants underwent\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT imaging within 6\u00a0months of diagnostic histopathology. Following extraction of PET parameters, we identified clinical and imaging predictors of mandibular recurrence-free survival (MRFS) using receiver operating characteristic curve analysis and multivariate Cox regression models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The results of histopathology revealed mandibular cancer recurrence in 24 patients (23.3%). Multivariate Cox regression analyses identified an age at diagnosis\u2009\u2264\u200952\u00a0years (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.013), a location of the SUVmax voxel with soft tissue predominance (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.019), and mandibular total lesion glycolysis (TLG)\u2009&gt;\u200962.68\u00a0g (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) as independent risk factors for MRFS. A scoring system was devised with scores from 0 (no risk factor) to 3 (presence of all three risk factors). High-risk patients with a score of 2\u20133 compared with score of 0\u20131 had a significantly higher likelihood of mandibular cancer recurrence (hazard ratio: 32.50, 95% confidence interval: 8.51\u2013124.18,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). The scoring system had a sensitivity of 87.50%, a specificity of 82.28%, and an accuracy of 83.50% for identifying mandibular cancer recurrence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The scoring system of our study is clinically useful for identifying mandibular cancer recurrence in patients with suspected ORN of the jaw.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13550-023-00965-8","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:03:10Z","timestamp":1680516190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The added values of 18F-FDG PET\/CT in differentiating cancer recurrence and osteoradionecrosis of mandible in patients with treated oral squamous cell carcinoma"],"prefix":"10.1186","volume":"13","author":[{"given":"Nai-Ming","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ta","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Din-Li","family":"Tsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hang","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0352-0277","authenticated-orcid":false,"given":"Tzu-Chen","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"965_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1054\/ijom.2002.0332","volume":"32","author":"T Reuther","year":"2003","unstructured":"Reuther T, Schuster T, Mende U, K\u00fcbler A. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients\u2014a report of a thirty year retrospective review. Int J Oral Maxillofac Surg. 2003;32:289\u201395. https:\/\/doi.org\/10.1054\/ijom.2002.0332.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"965_CR2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.ejso.2008.03.014","volume":"34","author":"P Pitak-Arnnop","year":"2008","unstructured":"Pitak-Arnnop P, Sader R, Dhanuthai K, Masaratana P, Bertolus C, Chaine A, et al. Management of osteoradionecrosis of the jaws: an analysis of evidence. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2008;34:1123\u201334. https:\/\/doi.org\/10.1016\/j.ejso.2008.03.014.","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"965_CR3","doi-asserted-by":"publisher","first-page":"106056","DOI":"10.1016\/j.oraloncology.2022.106056","volume":"133","author":"MM M\u00f6ring","year":"2022","unstructured":"M\u00f6ring MM, Mast H, Wolvius EB, Verduijn GM, Petit SF, Sijtsema ND, et al. Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: a retrospective cohort study. Oral Oncol. 2022;133:106056. https:\/\/doi.org\/10.1016\/j.oraloncology.2022.106056.","journal-title":"Oral Oncol"},{"key":"965_CR4","doi-asserted-by":"publisher","first-page":"105827","DOI":"10.1016\/j.oraloncology.2022.105827","volume":"128","author":"CT Chang","year":"2022","unstructured":"Chang CT, Liu SP, Muo CH, Liao YF, Chiu KM, Tsai CH, et al. The impact of dental therapy timelines and irradiation dosages on osteoradionecrosis in oral cancer patients: a population-based cohort study. Oral Oncol. 2022;128:105827. https:\/\/doi.org\/10.1016\/j.oraloncology.2022.105827.","journal-title":"Oral Oncol"},{"key":"965_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/s0278-2391(83)80005-6","volume":"41","author":"RE Marx","year":"1983","unstructured":"Marx RE. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg. 1983;41:351\u20137. https:\/\/doi.org\/10.1016\/s0278-2391(83)80005-6.","journal-title":"J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg"},{"key":"965_CR6","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.oraloncology.2010.08.007","volume":"46","author":"AS Jacobson","year":"2010","unstructured":"Jacobson AS, Buchbinder D, Hu K, Urken ML. Paradigm shifts in the management of osteoradionecrosis of the mandible. Oral Oncol. 2010;46:795\u2013801. https:\/\/doi.org\/10.1016\/j.oraloncology.2010.08.007.","journal-title":"Oral Oncol"},{"key":"965_CR7","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1097\/01.mlg.0000178374.29219.5e","volume":"115","author":"CC Wang","year":"2005","unstructured":"Wang CC, Cheng MH, Hao SP, Wu CC, Huang SS. Osteoradionecrosis with combined mandibulotomy and marginal mandibulectomy. Laryngoscope. 2005;115:1963\u20137. https:\/\/doi.org\/10.1097\/01.mlg.0000178374.29219.5e.","journal-title":"Laryngoscope"},{"key":"965_CR8","volume-title":"Osteoradionecrosis","author":"DD Davis","year":"2022","unstructured":"Davis DD, Hanley ME, Cooper JS. Osteoradionecrosis. Treasure Island: StatPearls; 2022."},{"key":"965_CR9","volume-title":"Mandible osteoradionecrosis","author":"LJ Zehr","year":"2022","unstructured":"Zehr LJ, Cooper JS. Mandible osteoradionecrosis. Treasure Island: StatPearls Publishing; 2022."},{"key":"965_CR10","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.1097\/rlu.0000000000002247","volume":"43","author":"Y Sanli","year":"2018","unstructured":"Sanli Y, Zukotynski K, Mittra E, Chen DL, Nadel H, Niederkohr RD, et al. Update 2018: 18F-FDG PET\/CT and PET\/MRI in head and neck cancer. Clin Nucl Med. 2018;43:e439\u201352. https:\/\/doi.org\/10.1097\/rlu.0000000000002247.","journal-title":"Clin Nucl Med"},{"key":"965_CR11","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/coa.13185","volume":"43","author":"CM Meerwein","year":"2018","unstructured":"Meerwein CM, Nakadate M, Stolzmann P, Vital D, Morand GB, Zweifel DF, et al. Contrast-enhanced 18F-FDG-PET\/CT for differentiating tumour and radionecrosis in head and neck cancer: our experience in 37 patients. Clin Otolaryngol Off J ENT-UK Off J Neth Soc Oto-Rhino-Laryngol Cervico-Fac Surg. 2018;43:1594\u20139. https:\/\/doi.org\/10.1111\/coa.13185.","journal-title":"Clin Otolaryngol Off J ENT-UK Off J Neth Soc Oto-Rhino-Laryngol Cervico-Fac Surg."},{"key":"965_CR12","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3174\/ajnr.A3879","volume":"35","author":"L Alhilali","year":"2014","unstructured":"Alhilali L, Reynolds AR, Fakhran S. Osteoradionecrosis after radiation therapy for head and neck cancer: differentiation from recurrent disease with CT and PET\/CT imaging. AJNR Am J Neuroradiol. 2014;35:1405\u201311. https:\/\/doi.org\/10.3174\/ajnr.A3879.","journal-title":"AJNR Am J Neuroradiol"},{"key":"965_CR13","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/1470-7330-14-s1-p3","volume":"14","author":"LI Sonoda","year":"2014","unstructured":"Sonoda LI, Lakhani A, Ghosh-Ray S. Prevalence of osteoradionecrosis demonstrated in 18F-FDG PET-CT of post-high-dose-radiotherapy head and neck cancer patients. Cancer Imaging. 2014;14:P3. https:\/\/doi.org\/10.1186\/1470-7330-14-s1-p3.","journal-title":"Cancer Imaging"},{"key":"965_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/01.rlu.0000170039.14351.0b","volume":"30","author":"GU Hung","year":"2005","unstructured":"Hung GU, Tsai SC, Lin WY. Extraordinarily high F-18 FDG uptake caused by radiation necrosis in a patient with nasopharyngeal carcinoma. Clin Nucl Med. 2005;30:558\u20139. https:\/\/doi.org\/10.1097\/01.rlu.0000170039.14351.0b.","journal-title":"Clin Nucl Med"},{"key":"965_CR15","first-page":"1301","volume":"36","author":"S Yamada","year":"1995","unstructured":"Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med Off Publ Soc Nucl Med. 1995;36:1301\u20136.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"965_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13550-020-00631-3","volume":"10","author":"NM Cheng","year":"2020","unstructured":"Cheng NM, Hsieh CE, Fang YD, Liao CT, Ng SH, Wang HM, et al. Development and validation of a prognostic model incorporating [(18)F]FDG PET\/CT radiomics for patients with minor salivary gland carcinoma. EJNMMI Res. 2020;10:74. https:\/\/doi.org\/10.1186\/s13550-020-00631-3.","journal-title":"EJNMMI Res"},{"key":"965_CR17","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jamaoto.2020.0014","volume":"146","author":"G Creff","year":"2020","unstructured":"Creff G, Devillers A, Depeursinge A, Palard-Novello X, Acosta O, Jegoux F, et al. Evaluation of the prognostic value of FDG PET\/CT parameters for patients with surgically treated head and neck cancer: a systematic review. JAMA Otolaryngol Head Neck Surg. 2020;146:471\u20139. https:\/\/doi.org\/10.1001\/jamaoto.2020.0014.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"965_CR18","doi-asserted-by":"publisher","first-page":"105593","DOI":"10.1016\/j.oraloncology.2021.105593","volume":"123","author":"NM Cheng","year":"2021","unstructured":"Cheng NM, Kang CJ, Tsai CY, Lee LY, Lin CY, Hsueh C, et al. Improved prognostic stratification of patients with pN3b oral cavity cancer based on maximum standardized uptake value of metastatic nodes, lymph node ratio, and level of cervical nodal metastases. Oral Oncol. 2021;123:105593. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105593.","journal-title":"Oral Oncol"},{"key":"965_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. AJCC cancer staging manual. 8th ed. New York: Springer; 2017.","edition":"8"},{"key":"965_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2967\/jnumed.116.180091","volume":"58","author":"JH Rasmussen","year":"2017","unstructured":"Rasmussen JH, N\u00f8rgaard M, Hansen AE, Vogelius IR, Aznar MC, Johannesen HH, et al. Feasibility of multiparametric imaging with PET\/MR in head and neck squamous cell carcinoma. J Nucl Med Off Publ Soc Nucl Med. 2017;58:69\u201374. https:\/\/doi.org\/10.2967\/jnumed.116.180091.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"965_CR21","doi-asserted-by":"publisher","first-page":"678729","DOI":"10.5402\/2011\/678729","volume":"2011","author":"K Hiasa","year":"2011","unstructured":"Hiasa K, Abe Y, Okazaki Y, Nogami K, Mizumachi W, Akagawa Y. Preoperative computed tomography-derived bone densities in hounsfield units at implant sites acquired primary stability. ISRN Dent. 2011;2011:678729. https:\/\/doi.org\/10.5402\/2011\/678729.","journal-title":"ISRN Dent"},{"key":"965_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2967\/jnumed.116.180919","volume":"58","author":"MC Desseroit","year":"2017","unstructured":"Desseroit MC, Tixier F, Weber WA, Siegel BA, Cheze Le Rest C, Visvikis D, et al. Reliability of PET\/CT shape and heterogeneity features in functional and morphologic components of non-small cell lung cancer tumors: a repeatability analysis in a prospective multicenter cohort. J Nucl Med Off Publ Soc Nucl Med. 2017;58:406\u201311. https:\/\/doi.org\/10.2967\/jnumed.116.180919.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"965_CR23","doi-asserted-by":"publisher","first-page":"248505","DOI":"10.1155\/2014\/248505","volume":"2014","author":"YH Fang","year":"2014","unstructured":"Fang YH, Lin CY, Shih MJ, Wang HM, Ho TY, Liao CT, et al. Development and evaluation of an open-source software package \u201cCGITA\u201d for quantifying tumor heterogeneity with molecular images. BioMed Res Int. 2014;2014:248505. https:\/\/doi.org\/10.1155\/2014\/248505.","journal-title":"BioMed Res Int"},{"key":"965_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A, Valli\u00e8res M, Abdalah MA, Aerts H, Andrearczyk V, Apte A, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295:328\u201338. https:\/\/doi.org\/10.1148\/radiol.2020191145.","journal-title":"Radiology"},{"key":"965_CR25","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/sim.7992","volume":"38","author":"RD Riley","year":"2019","unstructured":"Riley RD, Snell KI, Ensor J, Burke DL, Harrell FE Jr, Moons KG, et al. Minimum sample size for developing a multivariable prediction model: PART II\u2014binary and time-to-event outcomes. Stat Med. 2019;38:1276\u201396. https:\/\/doi.org\/10.1002\/sim.7992.","journal-title":"Stat Med"},{"key":"965_CR26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"key":"965_CR27","doi-asserted-by":"publisher","first-page":"e2011768","DOI":"10.1001\/jamanetworkopen.2020.11768","volume":"3","author":"YJ Tseng","year":"2020","unstructured":"Tseng YJ, Wang HY, Lin TW, Lu JJ, Hsieh CH, Liao CT. Development of a machine learning model for survival risk stratification of patients with advanced oral cancer. JAMA Netw Open. 2020;3:e2011768. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.11768.","journal-title":"JAMA Netw Open"},{"key":"965_CR28","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1601-0825.2010.01781.x","volume":"17","author":"E Jimi","year":"2011","unstructured":"Jimi E, Furuta H, Matsuo K, Tominaga K, Takahashi T, Nakanishi O. The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma. Oral Dis. 2011;17:462\u20138. https:\/\/doi.org\/10.1111\/j.1601-0825.2010.01781.x.","journal-title":"Oral Dis"},{"key":"965_CR29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000514229","volume":"83","author":"LKS Koyama","year":"2021","unstructured":"Koyama LKS, Nagano CP, Vanini JV, Figueredo JM Jr, Matos LL, Cernea CR, et al. Oral squamous cell carcinoma bone invasion: possible roles of E-cadherin in osteoclastogenesis and bone infiltration. ORL J Oto-Rhino-Laryngol Relat Spec. 2021;83:354\u201361. https:\/\/doi.org\/10.1159\/000514229.","journal-title":"ORL J Oto-Rhino-Laryngol Relat Spec"},{"key":"965_CR30","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3109\/0284186x.2010.498437","volume":"49","author":"PE Galavis","year":"2010","unstructured":"Galavis PE, Hollensen C, Jallow N, Paliwal B, Jeraj R. Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters. Acta Oncol (Stockholm, Sweden). 2010;49:1012\u20136. https:\/\/doi.org\/10.3109\/0284186x.2010.498437.","journal-title":"Acta Oncol (Stockholm, Sweden)"},{"key":"965_CR31","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.2967\/jnumed.115.156927","volume":"56","author":"J Yan","year":"2015","unstructured":"Yan J, Chu-Shern JL, Loi HY, Khor LK, Sinha AK, Quek ST, et al. Impact of image reconstruction settings on texture features in 18F-FDG PET. J Nucl Med Off Publ Soc Nucl Med. 2015;56:1667\u201373. https:\/\/doi.org\/10.2967\/jnumed.115.156927.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"965_CR32","doi-asserted-by":"publisher","first-page":"e75855","DOI":"10.1371\/journal.pone.0075855","volume":"8","author":"TS Chang","year":"2013","unstructured":"Chang TS, Chang CM, Ho HC, Su YC, Chen LF, Chou P, et al. Impact of young age on the prognosis for oral cancer: a population-based study in Taiwan. PLoS ONE. 2013;8:e75855. https:\/\/doi.org\/10.1371\/journal.pone.0075855.","journal-title":"PLoS ONE"},{"key":"965_CR33","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.oraloncology.2008.11.015","volume":"45","author":"AM De Paula","year":"2009","unstructured":"De Paula AM, Souza LR, Farias LC, Corr\u00eaa GT, Fraga CA, Eleut\u00e9rio NB, et al. Analysis of 724 cases of primary head and neck squamous cell carcinoma (HNSCC) with a focus on young patients and p53 immunolocalization. Oral Oncol. 2009;45:777\u201382. https:\/\/doi.org\/10.1016\/j.oraloncology.2008.11.015.","journal-title":"Oral Oncol"},{"key":"965_CR34","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1056\/NEJMoa073770","volume":"357","author":"ML Poeta","year":"2007","unstructured":"Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, Califano JA, et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med. 2007;357:2552\u201361. https:\/\/doi.org\/10.1056\/NEJMoa073770.","journal-title":"N Engl J Med"},{"key":"965_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1600-0714.2012.01142.x","volume":"41","author":"LS Monteiro","year":"2012","unstructured":"Monteiro LS, Diniz-Freitas M, Garcia-Caballero T, Warnakulasuriya S, Forteza J, Fraga M. Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2012;41:559\u201367. https:\/\/doi.org\/10.1111\/j.1600-0714.2012.01142.x.","journal-title":"J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol"},{"key":"965_CR36","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1080\/15384047.2015.1070985","volume":"16","author":"S Gupta","year":"2015","unstructured":"Gupta S, Khan H, Kushwaha VS, Husain N, Negi M, Ghatak A, et al. Impact of EGFR and p53 expressions on survival and quality of life in locally advanced oral squamous cell carcinoma patients treated with chemoradiation. Cancer Biol Ther. 2015;16:1269\u201380. https:\/\/doi.org\/10.1080\/15384047.2015.1070985.","journal-title":"Cancer Biol Ther"},{"key":"965_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bbacli.2014.11.004","volume":"3","author":"H Khan","year":"2015","unstructured":"Khan H, Gupta S, Husain N, Misra S, Mps N, Jamal N, et al. Correlation between expressions of Cyclin-D1, EGFR and p53 with chemoradiation response in patients of locally advanced oral squamous cell carcinoma. BBA Clin. 2015;3:11\u20137. https:\/\/doi.org\/10.1016\/j.bbacli.2014.11.004.","journal-title":"BBA Clin"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-023-00965-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-023-00965-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-023-00965-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:06:05Z","timestamp":1680516365000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-023-00965-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["965"],"URL":"https:\/\/doi.org\/10.1186\/s13550-023-00965-8","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"19 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of Chang Gung Medical Foundation (approval numbers: 202102071B0). The requirement for written patient informed consent was waived due to the retrospective study design. All study procedures were in accordance with the ethical standards of the institutional and national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}